Home / Lisinopril / Canada
CA ATC C09AA03 · updated 2 Nov 2026
Lisinopril shortage in Canada
Is there a Lisinopril shortage in Canada?
Yes. As of 2 Nov 2026, 6 Lisinopril products are reported short in Canada, the first since 12 Dec 2023. The company estimate for the return is 1 Dec 2026 (latest 2 Dec 2026). Main reason: active ingredient shortage.
Also short in Italy, Austria, Norway, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-LISINOPRIL (100 BTL) | APOTEX INC | 12 Dec 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-LISINOPRIL (100 BTL) | APOTEX INC | 2 Apr 2024 | not given | Active ingredient shortage Shortage of an active ingredient |
| CA | LISINOPRIL (100) | SIVEM PHARMACEUTICALS ULC | 10 Aug 2024 | 1 Dec 2026 | Active ingredient shortage Shortage of an active ingredient |
| CA | LISINOPRIL (100) | SIVEM PHARMACEUTICALS ULC | 10 Aug 2024 | 2 Dec 2026 | Active ingredient shortage Shortage of an active ingredient |
| CA | APO-LISINOPRIL (100 BTL) | APOTEX INC | 28 Jan 2025 | not given | Active ingredient shortage Shortage of an active ingredient |
| CA | LISINOPRIL (100) | SIVEM PHARMACEUTICALS ULC | 21 Mar 2025 | 1 Dec 2026 | Active ingredient shortage Shortage of an active ingredient |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.